Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

NCT04753385 is registered in ClinicalTrials.gov with LivaNova as lead sponsor.

NCT NCT04753385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04753385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes
Lead sponsor
LivaNova
Phase
Observational
Overall status
Terminated
Start date
March 23, 2021
Completion date
September 6, 2024
Enrollment
138 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression